Critical illness polyneuropathy and critical illness myopathy;Critical-Illness-Polyneuropathie und Critical-Illness-Myopathie

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 107, Issue 8, 2012, Pages 649-660

  Grimm, A ^a   Gunther A ^a   Witte, O W ^a   Axer, H ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Catecholamines; Glucose metabolism; Neuromuscular weakness; Sepsis; Systemic inflammatory response syndrome

Indexed keywords

CRITICAL ILLNESS; ELECTROPHYSIOLOGY; HOSPITALIZATION; HUMAN; LUNG VENTILATION; MUSCLE WEAKNESS; MYOPATHY; POLYNEUROPATHY; REVIEW; SEPSIS; WEANING;

EID: 84879585421     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-012-0186-y     Document Type: Review

References (31)

1. Axer H, Romeike B, Brunkhorst F et al (2011) Neurological sequelae of sepsis: II) neuromuscular weakness. Open Crit Care Med J 4: 8-14.
2. Bierbrauer J, Koch S, Olbricht C et al (2012) Early type II fiber atrophy in intensive care unit patients with nonexcitable muscle membrane. Crit Care Med 40: 647-650.
3. Bolton CF, Gilbert JJ, Hahn AF et al (1984) Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 47: 1223-1231.
4. Finfer S, Chittock DR, Su SY-S et al (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360: 1283-1297.
5. Fletcher SN, Kennedy DD, Ghosh IR et al (2003) Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 31: 1012-1016.
6. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL et al (2005) Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med 33: 349-354.
7. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL et al (2001) Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 27: 1288-1296.
8. Griffiths RD, Hall JB (2010) Intensive care unit-acquired weakness. Crit Care Med 38: 779-787.
9. Guarneri B, Bertolini G, Latronico N (2008) Long-term outcome in patients with critical illness myopathy or neuropathy: the Italian multicentre CRIMYNE study. J Neurol Neurosurg Psychiatry 79: 838-841.
10. Hermans G, De Jonghe B, Bruyninckx F et al (2008) Clinical review: Critical illness polyneuropathy and myopathy. Crit Care 12: 238.
11. Hermans G, Vanhorebeek I, Derde S et al (2009) Metabolic aspects of critical illness polyneuromyopathy. Crit Care Med 37: S391-397.
12. Khan J, Harrison TB, Rich MM et al (2006) Early development of critical illness myopathy and neuropathy in patients with severe sepsis. Neurology 67: 1421-1425.
13. Lacomis D, Giuliani MJ, van Cott A et al (1996) Acute myopathy of intensive care: clinical, electromyographic, and pathological aspects. Ann Neurol 40: 645-654.
14. Lacomis D, Zochodne DW, Bird SJ (2000) Critical illness myopathy. Muscle Nerve 23: 1785-1788.
15. Lacomis D (2011) Neuromuscular disorders in critically ill patients: review and update. J Clin Neuromuscul Dis 12: 197-218.
16. Latronico N, Bolton CF (2011) Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 10: 931-941.
17. Latronico N, Shehu I, Guarneri B (2009) Use of electrophysiologic testing. Crit Care Med 37: S316-320.
18. Lefaucheur J-P, Nordine T, Rodriguez P, Brochard L (2006) Origin of ICU acquired paresis determined by direct muscle stimulation. J Neurol Neurosurg Psychiatry 77: 500-506.
19. Novak KR, Nardelli P, Cope TC et al (2009) Inactivation of sodium channels underlies reversible neuropathy during critical illness in rats. J Clin Invest 119: 1150-1158.
20. Rochester CL (2009) Rehabilitation in the intensive care unit. Semin Respir Crit Care Med 30: 656-669.
21. Schaaf M van der, Beelen A, Vos R de (2004) Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil 26: 1189-1197.
22. Rich MM, Bird SJ, Raps EC et al (1997) Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 20: 665-673.
23. Stevens RD, Dowdy DW, Michaels RK et al (2007) Neuromuscular dysfunction acquired in critical illness: a systematic review. Intensive Care Med 33: 1876-1891.
24. Tennila A, Salmi T, Pettila V et al (2000) Early signs of critical illness polyneuropathy in ICU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 26: 1360-1363.
25. Trojaborg W (2006) Electrophysiologic techniques in critical illness-associated weakness. J Neurol Sci 242: 83-85.
26. Weber-Carstens S, Deja M, Koch S et al (2010) Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study. Crit Care 14: R119.
27. Weber-Carstens S, Koch S, Spuler S et al (2009) Nonexcitable muscle membrane predicts intensive care unit-acquired paresis in mechanically ventilated, sedated patients. Crit Care Med 37: 2632-2637.
28. Wehler M (2011) Langzeitprognose alter Patienten nach intensiv-medizinischer Behandlung. Med Klin Intensivmed Notfmed 106: 29-33.
29. Wieske L, Harmsen RE, Schultz MJ et al (2011) Is critical illness neuromyopathy and duration of mechanical ventilation decreased by strict glucose control? Neurocrit Care 14: 475-481.
30. Witt NJ, Zochodne DW, Bolton CF et al (1991) Peripheral nerve function in sepsis and multiple organ failure. Chest 99: 176-184.
31. Zink W, Kollmar R, Schwab S (2009) Critical illness polyneuropathy and myopathy in the intensive care unit. Nat Rev Neurol 5: 372-379.